SCHEMBL4160740

SCHEMBL4160740

Cc1ccc(C2(CC(=O)O)CCN(C(=O)OC(C)(C)C)CC2)cc1F

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.48
GPR119 Q8TDV5 3/20 0.42
ATM Q13315 1/20 0.41
RORC P51449 2/20 0.41
TSHR P16473 2/20 0.39
ALOX15 P16050 1/20 0.39
CCR5 P51681 3/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
THRB P10828 1/20 0.39
HSD11B1 P28845 1/20 0.39
DPP4 P27487 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166875 0.91 TACR1 (0.48) TACR1GPR119ATMRORCTSHR
SCHEMBL4542548 0.91 TACR1 (0.49) TACR1GPR119ATMRORCTSHR
SCHEMBL4416844 0.90 TACR1 (0.48) TACR1GPR119ATMTSHRALOX15
SCHEMBL10306241 0.88 MEN1 (0.49) TACR1ATMTSHRALOX15CCR5
SCHEMBL4161607 0.87 PDE4A (0.47) TACR1GPR119ATMRORCTSHR
SCHEMBL4159626 0.85 HSD11B1 (0.56) TACR1ATMRORCTSHRALOX15
SCHEMBL14272846 0.85 CCR5 (0.46) TACR1ATMTSHRALOX15CCR5
SCHEMBL10306289 0.84 TACR1 (0.50) TACR1GPR119ATMTSHRALOX15
SCHEMBL4551945 0.83 TACR1 (0.53) TACR1GPR119ATMRORCTSHR
SCHEMBL31693832 0.83 TACR1 (0.53) TACR1GPR119ATMRORCTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192194-A1 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them ALVARO GIUSEPPE 2009-07-30 US disclosed
US-20070073061-A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073061-A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them SLC6A4, OPRL1, HCRTR1 TACR1 9/4885GPR119 314/4885ATM 4788/4885
US-20090192194-A1 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them SLC6A4, OPRL1, HCRTR1 TACR1 9/4885GPR119 314/4885ATM 4788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.